Back to search

Plasma Verapamil Levels in Patients with Hypertrophic Cardiomyopathy: Interpatient Variability and Clinical Usefulness

Data up to Jan 2025

Published1982
Citations2
References30

Total Citations Per Year

Abstract

References (30)

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders. Part I: Basic and Clinical Electrophysiologic Effects

1980 • 332 citations

Protein Binding and Kinetics of Drugs in Liver Diseases

1977 • 262 citations

Physiological disposition of verapamil in man

1976 • 244 citations

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy. II. Effects on exercise capacity and symptomatic status.

1979 • 237 citations

Mechanism of left ventricular outflow obstruction in patients with obstructive asymmetric septal hypertrophy (Idiopathic hypertrophic subaortic stenosis)

1975 • 219 citations

Treatment of hypertrophic obstructive cardiomyopathy with verapamil.

1979 • 207 citations

Amelioration of Angina Pectoris in Idiopathic Hypertrophic Subaortic Stenosis with Beta-Adrenergic Blockade

1967 • 192 citations

Inotropic and electrophysiological actions of verapamil and D600 in mammalian myocardium

1975 • 174 citations

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

1981 • 169 citations

Calcium Channel Blocking Agents in the Treatment of Cardiovascular Disorders

1984 • 168 citations

The metabolism of DL-[14C]verapamil in man.

1979 • 167 citations

The Effect of Disease States on Drug Pharmacokinetics

1977 • 155 citations

Electrophysiologic and hemodynamic effects of verapamin. Correlation with plasma drug concentrations.

1978 • 150 citations

Comparative cardiovascular actions of verapamil and its major metabolites in the anaesthetised dog

1978 • 119 citations

Studies of the absorption and removal of propranolol in hypertensive patients during therapy.

1975 • 106 citations

Calciumantagonistische Therapie bei hypertroph-obstruktiver Kardiomyopathie

1976 • 94 citations

Verapamil therapy: a new approach to the pharmacologic treatment of hypertrophic cardiomyopathy.

1980 • 91 citations

The Pharmacology of Verapamil

1983 • 80 citations

Rapid high-pressure liquid chromatographic analysis of verapamil in blood and plasma

1979 • 72 citations

Relation of Propranolol Plasma Level to <i>β</i>-Blockade during Oral Therapy

1972 • 68 citations

Verapamil plasma levels and ventricular rate response in patients with atrial fibrillation and flutter

1979 • 61 citations

Verapamil and Norverapamil Plasma Concentrations During Long-Term Therapy in Patients with Hypertrophic Obstructive Cardiomyopathy

1980 • 54 citations

GLC Assay of Verapamil in Plasma: Identification of Fluorescent Metabolites after Oral Drug Administration

1979 • 41 citations

Analysis of verapamil in plasma by liquid chromatography

1980 • 39 citations

The pharmacology of verapamil. I. Elimination kinetics in dogs and correlation of plasma levels with effect on the eletrocardiogram.

1977 • 35 citations

Gas chromatographic determination of verapamil in plasma and urine.

1979 • 32 citations

Regional myocardial kinetics of lidocaine in experimental infarction: Modulation by regional blood flow

1981 • 18 citations

Contrasting pulmonary blood flow profiles in children with atrial and ventricular septal defects

1976 • 11 citations

Concentration dependent heart rate suppression with verapamil

1981 • 11 citations

Relationship between pharmacodynamics and myocardial concentration of verapamil

1981 • 10 citations

Cited By (0)

Loading...
Plasma Verapamil Levels in Patients with Hypertrophic Cardiomyopathy: Interpatient… (1982) – Springer eBooks | Metascience Observatory Explorer